Sun Pharma recall has once again brought attention to drug manufacturing standards and regulatory compliance in the United States.
.jpeg "Are Generic Cancer Drugs Driving India Pharma Growth?")
India’s generic cancer drug market is expanding with improved affordability, innovation, and access, as companies like Alembic advance complex oncology generics globally.
Gujarat’s Sickle Cell Mission has emerged as one of India’s most successful public health initiatives, with the state crossing 1.11 crore screenings for sickle cell disease.
The Centre's latest Dengue Preparedness Review comes at a crucial time as the monsoon season approaches and the risk of mosquito-borne diseases begins to rise across the country.
India’s HPV campaign has reached a major milestone, with nearly 50 lakh girls vaccinated within just three months of the nationwide rollout.
Moderna flu vaccine moved a step closer to market approval after an independent panel of advisers to the US Food and Drug Administration (FDA) unanimously backed the company's experimental shot for adults aged 50 years and older.
Midjourney, the AI image-generation startup known for creating digital art, is making an unexpected move into healthcare.
Lupin enters hypertension drug market as it announced the commercial launch of Azilsartan Medoxomil tablets in the United States.
Specialty drugs are becoming the next big growth driver for Indian pharmaceutical companies as the industry looks beyond traditional generic medicines.
Glenmark's drug launch could be a game changer as it expands its presence in the high-value rare disease segment.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")